{"title":"Pros and Cons of Alpha versus Beta Bone Seeking Agents in the Treatment of Cancer Pain","authors":"K. Liepe","doi":"10.1055/s-0043-1774731","DOIUrl":null,"url":null,"abstract":"Skeletal metastases occur in many types of solid malignant tumors, especially in advanced stage of prostate, breast, and lung cancers. The resulting bone pain affects patient ’ s quality of life and requires effective treatment. Only osteoblastic bone metastases are suitable for treatment with bone-seeking agents. Typical tumors are prostate cancer with 65 to 85% of bone metastases, breast cancer with 65 to 75%, and small cell lung cancer with 34 to 50%, respectively. 1 The mechanisms involved in bone pain are poorly understood, 2 but are likely to be a consequence of osteolysis (bone breakdown). 3 In fi ltration of the bone trabeculae and matrix by tumor osteolysis is one of the physical factors. Pain may result from instability-based microfractures and stretching of the periosteum by tumor growth. 4 The pathophysiological mechanisms of pain include stimulation of free nerve endings in the endosteum bya variety ofchemical mediators like bradykinin,prostaglandin, histamine, interleukin, and tumor necrosis factor. 4,5","PeriodicalId":23742,"journal":{"name":"World Journal of Nuclear Medicine","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1774731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Skeletal metastases occur in many types of solid malignant tumors, especially in advanced stage of prostate, breast, and lung cancers. The resulting bone pain affects patient ’ s quality of life and requires effective treatment. Only osteoblastic bone metastases are suitable for treatment with bone-seeking agents. Typical tumors are prostate cancer with 65 to 85% of bone metastases, breast cancer with 65 to 75%, and small cell lung cancer with 34 to 50%, respectively. 1 The mechanisms involved in bone pain are poorly understood, 2 but are likely to be a consequence of osteolysis (bone breakdown). 3 In fi ltration of the bone trabeculae and matrix by tumor osteolysis is one of the physical factors. Pain may result from instability-based microfractures and stretching of the periosteum by tumor growth. 4 The pathophysiological mechanisms of pain include stimulation of free nerve endings in the endosteum bya variety ofchemical mediators like bradykinin,prostaglandin, histamine, interleukin, and tumor necrosis factor. 4,5